ART-CC (Antiretroviral Therapy Cohort Collaboration) (coordinated by Prof. Jonathan Sterne, University of Bristol) is a long-standing international collaboration, including 19 cohort studies in Europe and North America. ART-CC was initiated to carry out prognostic studies to assess the effect of cART in therapy-naive patients. In 2017, Prof. Peter Reiss and Dr Ard van Sighem represented SHM in ART-CC.
In 2017, the following articles were published for ART-CC:
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
The Antiretroviral Therapy Cohort Collaboration.
Lancet HIV 2017 Published Online May 10, 2017 http://dx.doi.org/10.1016/S2352-3018(17)30066-8
CD4:CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus-infected patients on antiretroviral therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, Monforte AD, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola D, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
Clin Infect Dis. 2017 Sep 15;65(6):959-966. doi: 10.1093/cid/cix466
Antiretroviral pill count and clinical outcomes in treatment naive patients with HIV
Young J, Smith C, Teira R, Reiss P, Jarrín Vera I, Crane H, Miro JM, D'Arminio Monforte A, Saag M, Zangerle R, Bucher HC; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2017 Nov 6. doi: 10.1111/hiv.12562. [Epub ahead of print]